Alvogen competitors

CEO with nearly 30 years of diverse experience predominately in general management and business development. Background in both high-value diagnostics and therapeutics with management experience covering numerous areas including general management, sales and marketing, business development, strategic planning, research & development, commercial assessment and portfolio management.

Timothy Crew is a Chief Executive Officer at LANNETT CO INC and Board Member at LANNETT CO INC. He has worked as VP:Alliances & Business Development at Teva Pharmaceutical Indus Ltd, Captain at United States Army, and CEO:North America at cipla. Timothy works or has worked at BRISTOL MYERS SQUIBB CO. He attended Columbia Graduate School of Business and Pomona.

Richard Maradie is a Chief Executive Officer at NOVAVAX INC and is based in Rockville, Maryland.

Joseph P. “Jay” Hagan joined Regulus in January 2016 as Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer and was appointed to President and Chief Executive Officer in May 2017. Mr. Hagan’s career includes roles as the Executive Vice President, Chief Financial Officer and Chief Business Officer of Orexigen Therapeutics, Inc., Managing Director of Amgen Ventures and head of corporate development for Amgen Inc. Mr. Hagan has led numerous strategic and financing transactions including the acquisitions of Immunex and Tularik and the spinout of Novantrone and Relyspa, as well as many other business development efforts totaling over $15 billion in value. Before joining Amgen, Mr. Hagan spent five years in the bioengineering labs at Genzyme and Advanced Tissue Sciences. Mr. Hagan currently serves on the board of directors of Zosano Pharma, a publicly traded biotechnology company. He received an M.B.A. from Northeastern University and a B.S. in Physiology and Neuroscience from the University of California, San Diego.

Mr. Sunil Bhonsle, M.B.A has been the President of Titan Pharmaceuticals Inc. since 2009 and serves as its Principal Executive Officer, Principal Financial Officer and Secretary. Mr. Bhonsle served as Executive Vice President and Chief Operating Officer of Titan Pharmaceuticals Inc. since September 1995. Mr. Bhonsle served as Vice President and General Manager-Plasma Supply and Manager-Inventory and Technical Planning, of Bayer Corporation From July 1975 to April 1995. He has been a Director of Titan Pharmaceuticals Inc., since February 2004. He Holds an MBA from the University of California at Berkeley and a B.Tech. in Chemical Engineering from The Indian Institute of Technology.